查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1717093

医疗设备报销市场（按付款人展望、设备类型、设备分类、应用和最终用户）—2025-2030 年全球预测

Medical Devices Reimbursement Market by Payer Outlook, Device Type, Device Classification, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2024 年医疗设备报销市场价值将达到 5,748 亿美元，到 2025 年将成长至 6,182.5 亿美元，复合年增长率为 7.73%，到 2030 年将达到 8987.8 亿美元。

主要市场统计数据
基准年2024年 5748亿美元
预计2025年 6182.5亿美元
预测年份 2030 8987.8亿美元
复合年增长率（%） 7.73%

在当今快速发展的医疗保健环境中，了解医疗设备报销的复杂性对于策略和营运成功至关重要。这项全面的分析深入探讨了影响报销流程和医疗设备金融生态系统的关键因素。它强调了监管变化、技术创新和付款人动态的变化将如何影响报销策略。

所考虑的背景不仅是由先进治疗方法和设备的引入所定义的，而且还由平衡成本效益和提供优质医疗服务的新挑战所定义。包括政策制定者、医疗保健提供者和製造商在内的多方相关人员在决策流程中日益紧密地联繫在一起，以确保财务模型能够支持创新和永续性。

本报告深入探讨了市场驱动因素、固有监管风险和未来趋势。它整合了当前的市场讯息，并提供了关键细分市场如何适应当代挑战的见解。透过深入的分析和前瞻性的观点，它旨在为决策者提供资讯和权力，为应对医疗设备复杂的报销动态提供坚实的基础。

市场动态正处于转折点

该行业已经经历了一场转型转变，重新定义传统模式并加快报销模式演变的步伐。经济压力和快速的技术创新开始在改变报销格局方面发挥关键作用。

近年来，医疗照护已转向以价值为基础的模式，这种模式更注重绩效和结果而非数量。远端医疗平台和人工智慧诊断工具等数位健康技术的整合正在进一步加速这一变化。这些进步正在将医疗保健报销模式从静态的按服务收费安排转变为奖励效率、优质结果和以患者为中心的护理的更细緻的框架。

监管机构也重新调整了评估方法，更加重视临床效果和长期成本节约。因此，製造商必须调整产品系列以满足更严格的基准并满足不断变化的付款人期望。随着相关人员探索承诺共用担风险​​和回报的创新合约安排，人们越来越重视综合照护模式。总的来说，这些转型转变强调了在不断变化的环境中取得成功需要敏捷和前瞻性的方法。

推动产业趋势的关键细分洞察

对市场区隔的详细评估为理解影响报销策略的众多因素提供了重要的蓝图。分析首先检视付款人格局，将市场分为私人市场和公共市场。这种二分法有助于理解每个付款人固有的不同报销标准和经济预期。

此外，观察不同类型的医疗设备就会发现其结构是多方面的。我们从消耗品和一次性用品、诊断影像设备、行动辅助设备和治疗设备的角度研究市场。消耗品和一次性用品受到严格审查，注射器、针头和创伤护理产品等关键物品受到审查。影像设备又细分为CT扫描仪、磁振造影设备、超音波设备和X光设备，它们共同代表技术创新。治疗设备分析包括透析设备、输液系统和呼吸治疗设备，其中呼吸治疗设备又细分为氧气疗法设备和人工呼吸器，突显了呼吸照护的重要性。

此外，根据设备分类的审查将产品分为 I 类、II 类和 III 类。基于应用的细分更深入地研究了心臟病学、神经病学、肿瘤学和整形外科领域。这里，循环系统进一步分为心律管理设备和介入性循环系统设备，神经科为脑脊髓液管理设备和神经刺激设备，肿瘤学分为化疗管理设备和放射治疗设备，整形外科分为关节重组设备和脊椎外科设备。最后，对最终用户进行调查，包括门诊手术中心、家庭医疗保健和医院/诊所，后者进一步细分为住院患者和门诊病人。这种细分提供了对市场驱动因素和市场差距的详细了解。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 需要专门设备的慢性病增多
      • 政府和私部门增加医疗支出
    • 限制因素
      • 消费者对获得核准和确定报销资格的担忧
    • 机会
      • 随着远端医疗和数位健康解决方案的扩展，连网型设备的兴起
    • 任务
      • 在设备使用和报销方面对保护患者资料的担忧
  • 市场区隔分析
    • 付款人观点：公共付款人对广泛获取和标准化流程的重要性
    • 最终用户：医院和诊所利用医疗设备报销来满足不同病患的需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章医疗设备报销市场（以付款人划分）展望

  • 私人的
  • 公共

第七章医疗设备报销市场（依设备类型）

  • 消耗品和一次性用品
    • 注射器和针头
    • 创伤护理产品
  • 诊断影像设备
    • 电脑断层扫描（CT）扫描仪
    • 磁振造影（MRI）设备
    • 超音波设备
    • X射线系统
  • 助行辅助器
  • 处理设备
    • 透析设备
    • 输液系统
    • 呼吸治疗设备
      • 氧气疗法设备
      • 人工呼吸器

第八章医疗设备报销市场（依设备分类）

  • I类
  • II 类
  • III 类

第九章医疗设备报销市场（按应用）

  • 心臟病学
    • 心律管理
    • 介入心臟器械
  • 神经病学
    • 脑脊髓液管理
    • 神经刺激设备
  • 肿瘤学
    • 化疗的实施
    • 放射治疗设备
  • 整形外科
    • 关节重组
    • 脊椎手术设备

第 10 章医疗设备报销市场（按最终用户）

  • 门诊手术中心
  • 家庭医疗保健
  • 医院和诊所
    • 住院护理
    • 门诊护理

第 11 章：美洲医疗设备报销市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太医疗设备报销市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲医疗设备报销市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AiM GmbH
  • Allianz SE
  • Anco Insurance
  • Anthem Insurance Companies, Inc.
  • Aviva PLC
  • BNP Paribas
  • CVS Health Corporation
  • European Med Tech and IVD Reimbursement Consulting Ltd.
  • Hamilton Leigh Ltd.
  • HUB International Limited
  • Humana Inc.
  • MCRA, LLC
  • mdiConsultants, Inc.
  • Medmarc Insurance Group
  • North American Science Associates, Inc.
  • Reliance Nippon Life Insurance Company
  • UnitedHealth Group
  • UnitedHealth Group Incorporated
  • WellCare Health Plans, Inc.
  • WS Value & Dossier GmbH
  • XIFIN, Inc.
Product Code: MRR-205091A88A65

The Medical Devices Reimbursement Market was valued at USD 574.80 billion in 2024 and is projected to grow to USD 618.25 billion in 2025, with a CAGR of 7.73%, reaching USD 898.78 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 574.80 billion
Estimated Year [2025] USD 618.25 billion
Forecast Year [2030] USD 898.78 billion
CAGR (%) 7.73%

In today's rapidly evolving healthcare environment, understanding the complexities of medical devices reimbursement is critical for strategic planning and operational success. This comprehensive analysis delves into the critical factors shaping reimbursement processes and the financial ecosystem surrounding medical devices. It highlights how reimbursement strategies are increasingly influenced by regulatory changes, technological innovations, and shifts in payer dynamics.

The landscape under review is not only defined by the introduction of advanced treatments and devices but also by the emerging challenges in aligning cost efficiency with high-quality healthcare delivery. Several stakeholders, including policymakers, healthcare providers, and manufacturers, are now more intertwined in the decision-making process, ensuring that financial models support both innovation and sustainability.

This report provides an in-depth exploration of market drivers, inherent regulatory risks, and future trends. It synthesizes current market intelligence and offers insights into how key market segments are adapting to contemporary challenges. Through detailed analysis and a forward-looking perspective, the discussion aims to inform and empower decision-makers, offering them a robust foundation to navigate the intricate reimbursement dynamics in medical devices.

Transformative Shifts in the Market Dynamics

The industry has witnessed transformative shifts that have redefined traditional models and accelerated the pace at which reimbursement paradigms evolve. Increasingly, economic pressures and rapid technological innovations have played a significant role in altering the reimbursement landscape.

Recent years have seen a migration toward value-based care which encourages performance and outcomes rather than sheer volume. The integration of digital health technologies, including telemedicine platforms and AI-driven diagnostic tools, has further catalyzed these changes. These advancements have transitioned reimbursement models from static fee-for-service arrangements to more nuanced frameworks that reward efficiency, quality outcomes, and patient-centered care.

Regulatory bodies have also recalibrated their assessment methodologies, placing greater emphasis on clinical efficacy and long-term cost savings. As a result, manufacturers have had to tailor their product portfolios to meet stricter benchmarks and to align with evolving payer expectations. Emphasis on integrated care models is increasingly evident, as stakeholders explore innovative contractual arrangements that promise shared risk and reward. Overall, these transformative shifts emphasize the need for agility and a forward-thinking approach in order to thrive amidst an ever-changing landscape.

Critical Segmentation Insights Driving Industry Trends

A detailed evaluation of market segmentation provides an essential blueprint for understanding the myriad factors influencing reimbursement strategies. The analysis begins by looking at payer outlooks which categorizes the market into private and public segments. Such bifurcation makes it possible to appreciate the different reimbursement criteria and financial expectations intrinsic to each payer.

Further, an examination based on device type reveals a multifaceted structure. The market is studied through the lens of consumables and disposables, diagnostic imaging equipment, mobility aids, and therapeutic devices. In-depth scrutiny of consumables and disposables breaks out key items like syringes and needles as well as wound care products. Diagnostic imaging equipment is further subdivided into computed tomography scanners, magnetic resonance imaging equipment, ultrasound devices, and X-ray systems which collectively showcase technological innovations. Therapeutic devices are analyzed by considering dialysis equipment, infusion systems, and respiratory therapy devices; the latter is intricately divided into oxygen therapy equipment and ventilators, emphasizing the critical nature of respiratory care.

Additionally, a review based on device classification segments products into Class I, Class II, and Class III. The application-based segmentation takes a closer look at the areas of cardiology, neurology, oncology, and orthopedics. Here, cardiology is further segmented into cardiac rhythm management and interventional cardiology devices, neurology into cerebrospinal fluid management and neurostimulation devices, oncology into chemotherapy administration and radiation therapy equipment, while orthopedics is bifurcated into joint reconstruction and spinal surgery devices. Finally, when considering end-users, the framework examines ambulatory surgical centers, home healthcare, and hospitals and clinics where the latter is further segmented into in-patient and out-patient care. These segmentation insights afford a granular appreciation of market drivers and disparities.

Based on Payer Outlook, market is studied across Private and Public.

Based on Device Type, market is studied across Consumables and Disposables, Diagnostic Imaging Equipment, Mobility Aids, and Therapeutic Devices. The Consumables and Disposables is further studied across Syringes & Needles and Wound Care Products. The Diagnostic Imaging Equipment is further studied across Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Ultrasound Devices, and X-Ray Systems. The Therapeutic Devices is further studied across Dialysis Equipment, Infusion Systems, and Respiratory Therapy Devices. The Respiratory Therapy Devices is further studied across Oxygen Therapy Equipment and Ventilators.

Based on Device Classification, market is studied across Class I, Class II, and Class III.

Based on Application, market is studied across Cardiology, Neurology, Oncology, and Orthopedics. The Cardiology is further studied across Cardiac Rhythm Management and Interventional Cardiology Devices. The Neurology is further studied across Cerebrospinal Fluid Management and Neurostimulation Devices. The Oncology is further studied across Chemotherapy Administration and Radiation Therapy Equipment. The Orthopedics is further studied across Joint Reconstruction and Spinal Surgery Devices.

Based on End-User, market is studied across Ambulatory Surgical Centers, Home Healthcare, and Hospitals & Clinics. The Hospitals & Clinics is further studied across In-patient Care and Out-patient Care.

Regional Dynamics and Growth Opportunities in Global Markets

The global medical devices reimbursement arena is marked by significant regional diversity, which in turn shapes strategic investment and operational priorities. The analysis draws on recent trends observed across major regions. In the Americas, evolving payer models and increasing adoption of advanced technologies have reshaped market dynamics, spurring both innovation and competitive pricing structures.

In the Europe, Middle East & Africa region, a rich blend of regulatory frameworks and diverse economic conditions has resulted in a unique mix of challenges and opportunities. Stakeholders in this region benefit from concerted efforts toward regulatory harmonization coupled with market-driven reforms that foster enhanced interconnectivity between healthcare providers and insurers.

The Asia-Pacific region stands out as a hotbed of growth, marked by rapidly evolving infrastructure, a rising middle class, and increasing healthcare expenditures. This dynamic environment provides fertile ground for both established and emerging players to capitalize on new market segments. The nuanced differences and similarities across these regions underline the importance of a tailored strategic approach to meet localized demands while maintaining a global perspective.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insightful Analysis of Prominent Market Players and Their Strategies

The competitive landscape is defined by a diverse set of companies that bring varying strengths and strategic orientations to the table. Market leaders demonstrate a rich tapestry of innovation, risk management, and flexible service offerings, which redefines success in reimbursement strategies. Established firms such as AiM GmbH and Allianz SE have carved out leadership positions by leveraging their deep market expertise and maintaining a strong commitment to quality. Other major stakeholders including Anco Insurance and Anthem Insurance Companies, Inc. have successfully aligned their strategies with emerging digital trends and regulatory expectations, thereby fortifying their market presence.

Furthermore, companies like Aviva PLC, BNP Paribas, and CVS Health Corporation remain at the forefront of shaping market directions through collaborative initiatives and integrated service models. European Med Tech and IVD Reimbursement Consulting Ltd. and Hamilton Leigh Ltd. are distinguished by their focused approach on bridging clinical innovations with reimbursement realities. HUB International Limited and Humana Inc., along with MCRA, LLC and mdiConsultants, Inc., have expanded their expertise by closely monitoring evolving payer dynamics. Medmarc Insurance Group and North American Science Associates, Inc. further complement this competitive mix with their commitment to leveraging technology and data analytics. Reliance Nippon Life Insurance Company, UnitedHealth Group and its incorporated counterpart, WellCare Health Plans, Inc., WS Value & Dossier GmbH, and XIFIN, Inc. round out a comprehensive competitive overview, reflecting a blend of approaches that are both innovative and responsive to market changes.

The report delves into recent significant developments in the Medical Devices Reimbursement Market, highlighting leading vendors and their innovative profiles. These include AiM GmbH, Allianz SE, Anco Insurance, Anthem Insurance Companies, Inc., Aviva PLC, BNP Paribas, CVS Health Corporation, European Med Tech and IVD Reimbursement Consulting Ltd., Hamilton Leigh Ltd., HUB International Limited, Humana Inc., MCRA, LLC, mdiConsultants, Inc., Medmarc Insurance Group, North American Science Associates, Inc., Reliance Nippon Life Insurance Company, UnitedHealth Group, UnitedHealth Group Incorporated, WellCare Health Plans, Inc., WS Value & Dossier GmbH, and XIFIN, Inc.. Actionable Strategic Recommendations for Market Leaders

For industry leaders navigating the complex reimbursement terrain, actionable strategies are critical to harness the full potential of market opportunities. It is imperative to invest in advanced data analytics and robust forecasting tools to accurately track market shifts and payer behavior. Enhanced collaboration with regulatory bodies can also pave the way for smoother dossier preparation and faster reimbursement cycles. Integrating bespoke digital solutions, particularly in the realm of telehealth and AI-enhanced diagnostic capabilities, can significantly optimize cost management and operational efficiency.

Furthermore, it is advisable to foster cross-functional partnerships that integrate clinical expertise with commercial acumen. Adopting a customer-centric approach by actively engaging with both private and public payers will enable more nuanced pricing strategies that reflect the true value of medical innovations. Emphasis should be placed on continuous staff training to ensure familiarity with emerging trends and regulatory updates. Leaders are encouraged to benchmark against best practices from peer institutions and to remain agile in strategy recalibration, ensuring that product portfolios remain aligned with evolving reimbursement frameworks.

Conclusion: Strategic Pathways for the Future of Medical Device Reimbursement

In summary, the dynamic landscape of medical devices reimbursement demands a multifaceted approach that is both agile and informed by rigorous market analysis. The critical insights drawn from segmentation, regional diversity, and competitive pressures underscore an industry at a crossroads where traditional models are being redefined by innovation and regulatory shifts. Stakeholders today must balance efficiency with effectiveness in order to respond to the increasing complexity of payer demands and technological innovations.

As the market continues to mature, successful navigation will depend on the ability to anticipate trends and create adaptive strategies that align financial outcomes with clinical benefits. This comprehensive summary reinforces the notion that understanding the interplay between policy, technology, and market segmentation is essential. Ultimately, the future will belong to those who can integrate diverse insights into actionable plans, thereby ensuring sustained growth and improved patient outcomes in the medical devices reimbursement arena.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic conditions with need for specialised devices
      • 5.1.1.2. Rising healthcare spending by government and private sectors
    • 5.1.2. Restraints
      • 5.1.2.1. Consumer concerns associated with obtaining approvals and establishing reimbursement eligibility
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of connected devices with expansion of telemedicine and digital health solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns assocaited with the protection of patient data in the context of device usage and reimbursement
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Payer Outlook: Significance of public payer for broad access and standardized processes
    • 5.2.2. End-User: Utilization of medical devices reimbursement in hospitals & clinics to serve diverse patient needs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Devices Reimbursement Market, by Payer Outlook

  • 6.1. Introduction
  • 6.2. Private
  • 6.3. Public

7. Medical Devices Reimbursement Market, by Device Type

  • 7.1. Introduction
  • 7.2. Consumables and Disposables
    • 7.2.1. Syringes & Needles
    • 7.2.2. Wound Care Products
  • 7.3. Diagnostic Imaging Equipment
    • 7.3.1. Computed Tomography (CT) Scanners
    • 7.3.2. Magnetic Resonance Imaging (MRI) Equipment
    • 7.3.3. Ultrasound Devices
    • 7.3.4. X-Ray Systems
  • 7.4. Mobility Aids
  • 7.5. Therapeutic Devices
    • 7.5.1. Dialysis Equipment
    • 7.5.2. Infusion Systems
    • 7.5.3. Respiratory Therapy Devices
      • 7.5.3.1. Oxygen Therapy Equipment
      • 7.5.3.2. Ventilators

8. Medical Devices Reimbursement Market, by Device Classification

  • 8.1. Introduction
  • 8.2. Class I
  • 8.3. Class II
  • 8.4. Class III

9. Medical Devices Reimbursement Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiology
    • 9.2.1. Cardiac Rhythm Management
    • 9.2.2. Interventional Cardiology Devices
  • 9.3. Neurology
    • 9.3.1. Cerebrospinal Fluid Management
    • 9.3.2. Neurostimulation Devices
  • 9.4. Oncology
    • 9.4.1. Chemotherapy Administration
    • 9.4.2. Radiation Therapy Equipment
  • 9.5. Orthopedics
    • 9.5.1. Joint Reconstruction
    • 9.5.2. Spinal Surgery Devices

10. Medical Devices Reimbursement Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Home Healthcare
  • 10.4. Hospitals & Clinics
    • 10.4.1. In-patient Care
    • 10.4.2. Out-patient Care

11. Americas Medical Devices Reimbursement Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Medical Devices Reimbursement Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Medical Devices Reimbursement Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Inari Medical secures reimbursement for ClotTriever in Japan, partners with Medikit for strategic distribution
    • 14.3.2. UK medical device companies benefit from Medilink and Medical Alley partnership on reimbursement pathways
    • 14.3.3. Medicare's new reimbursement rule enhances market access for FDA breakthrough medical devices
    • 14.3.4. Bipartisan call for CMS to establish a cohesive reimbursement pathway for AI-enabled medical devices
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AiM GmbH
  • 2. Allianz SE
  • 3. Anco Insurance
  • 4. Anthem Insurance Companies, Inc.
  • 5. Aviva PLC
  • 6. BNP Paribas
  • 7. CVS Health Corporation
  • 8. European Med Tech and IVD Reimbursement Consulting Ltd.
  • 9. Hamilton Leigh Ltd.
  • 10. HUB International Limited
  • 11. Humana Inc.
  • 12. MCRA, LLC
  • 13. mdiConsultants, Inc.
  • 14. Medmarc Insurance Group
  • 15. North American Science Associates, Inc.
  • 16. Reliance Nippon Life Insurance Company
  • 17. UnitedHealth Group
  • 18. UnitedHealth Group Incorporated
  • 19. WellCare Health Plans, Inc.
  • 20. WS Value & Dossier GmbH
  • 21. XIFIN, Inc.

LIST OF FIGURES

  • FIGURE 1. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-CURRENCY
  • FIGURE 2. MEDICAL DEVICES REIMBURSEMENT MARKET MULTI-LANGUAGE
  • FIGURE 3. MEDICAL DEVICES REIMBURSEMENT MARKET RESEARCH PROCESS
  • FIGURE 4. MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. MEDICAL DEVICES REIMBURSEMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. MEDICAL DEVICES REIMBURSEMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL DEVICES REIMBURSEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL DEVICES REIMBURSEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY MOBILITY AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIALYSIS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OXYGEN THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CHEMOTHERAPY ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RADIATION THERAPY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY SPINAL SURGERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY IN-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY OUT-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 113. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. CANADA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 127. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. MEXICO MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED STATES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. AUSTRALIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 185. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. CHINA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 199. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. INDIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 213. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. INDONESIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 227. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. JAPAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 241. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. MALAYSIA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 252. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. PHILIPPINES MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 266. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 269. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. SINGAPORE MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH KOREA MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 291. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE CLASSIFICATION, 2018-2030 (USD MILLION)
  • TABLE 292. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2030 (USD MILLION)
  • TABLE 297. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. TAIWAN MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY PAYER OUTLOOK, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY CONSUMABLES AND DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND MEDICAL DEVICES REIMBURSEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND MEDICAL DEVICES REIM